mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models. - Agrawal N; Ates LS; Schille SA; Chaturvedi A; Vogt J; Vukovic N; Dulberger CL; Vogel AB; Diekmann J; Diken M; Şahin U (Nature immunology, 2026)